“Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin” (2024) ACTA MEDICA PERUANA, 28(4), pp. 188–193. Available at: https://amp.cmp.org.pe/index.php/AMP/article/view/1118 (Accessed: 25 December 2024).